SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E62AD4A8D4ED7B873CAD1E84213D6CBF48AFB277AC0B87D91724B252C981824714A65F3071AE441FB61119D2D664ED1B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E62AD4A8D4ED7B873CAD1E84213D6CBF48AFB277AC0B87D91724B252C981824714A65F3071AE441FB61119D2D664ED1B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E62AD4A8D4ED7B873CAD1E84213D6CBF48AFB277AC0B87D91724B252C981824714A65F3071AE441FB61119D2D664ED1B
http://www.w3.org/2000/01/rdf-schema#comment
"In this trial arginine deprivation with ADI-PEG20 improved PFS in patients with ASS1-deficient mesothelioma. Targeting arginine is safe and warrants further clinical investigation in arginine-dependent cancers."
xsd:string
http://purl.uniprot.org/uniprot/#_77F151E134A41AD9D32D5C67A0A9655531ED752C35480E4A1BB0718C40F08E8FA80ACF572DCFEE38BBC1DA03BDFE0ACE
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E62AD4A8D4ED7B873CAD1E84213D6CBF48AFB277AC0B87D91724B252C981824714A65F3071AE441FB61119D2D664ED1B
http://purl.uniprot.org/uniprot/Q5T6L4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E62AD4A8D4ED7B873CAD1E84213D6CBF48AFB277AC0B87D91724B252C981824714A65F3071AE441FB61119D2D664ED1B
http://purl.uniprot.org/uniprot/#_Q5T6L4-mappedCitation-27584578
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E62AD4A8D4ED7B873CAD1E84213D6CBF48AFB277AC0B87D91724B252C981824714A65F3071AE441FB61119D2D664ED1B